78 results on '"Geisbert, Thomas W."'
Search Results
2. Marburg and Ravn Viruses Fail to Cause Disease in the Domestic Ferret ( Mustela putorius furo )
3. Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates
4. Comparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and Humans
5. Role of Antibodies in Protection Against Ebola Virus in Nonhuman Primates Immunized With Three Vaccine Platforms
6. Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates
7. Modelling Marburg Virus Disease in Syrian Golden Hamsters: Contrasted Virulence between Angola and Ci67 strains
8. Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector Meeting
9. Limited benefit of post-exposure prophylaxis with VSV-EBOV in Ebola virus-infected rhesus macaques
10. Long-term Prophylaxis Against Aerosolized Marburg Virus in Nonhuman Primates With an Afucosylated Monoclonal Antibody
11. Natural History of Nonhuman Primates After Oral Exposure to Ebola Virus Variant Makona
12. A highly attenuated pan-filovirus VesiculoVax vaccine rapidly protects nonhuman primates against Marburg virus and three species of Ebolavirus
13. Pathogenesis of Aerosolized Ebola Virus Variant Makona in Nonhuman Primates
14. An Outbreak of Ebola Virus Disease in the Lassa Fever Zone
15. Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection
16. Molecular Diagnostic Field Test for Point-of-Care Detection of Ebola Virus Directly From Blood
17. Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus
18. Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates
19. Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection
20. The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus
21. Development of Prototype Filovirus Recombinant Antigen Immunoassays
22. Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model
23. Lack of Marburg Virus Transmission From Experimentally Infected to Susceptible In-Contact Egyptian Fruit Bats
24. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus
25. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection
26. Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines
27. A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs
28. Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig
29. Protection Against Lethal Marburg Virus Infection Mediated by Lipid Encapsulated Small Interfering RNA
30. Interferon-β Therapy Prolongs Survival in Rhesus Macaque Models of Ebola and Marburg Hemorrhagic Fever
31. A Recently Isolated Lassa Virus From Mali Demonstrates Atypical Clinical Disease Manifestations and Decreased Virulence in Cynomolgus Macaques
32. Pathogenesis of Marburg Hemorrhagic Fever in Cynomolgus Macaques
33. Single Immunization With a Monovalent Vesicular Stomatitis Virus-Based Vaccine Protects Nonhuman Primates Against Heterologous Challenge With Bundtbugyo ebolavirus
34. Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany
35. Vesicular Stomatitis Virus-Based Ebola Vaccines With Improved Cross-Protective Efficacy
36. Therapeutics of Ebola Hemorrhagic Fever: Whole–Genome Transcriptional Analysis of Successful Disease Mitigation
37. Recombinant Vesicular Stomatitis Virus-Based Vaccines Against Ebola and Marburg Virus Infections
38. In vitro and in vivo Characterization of Recombinant Ebola Viruses Expressing Enhanced Green Fluorescent Protein
39. Outbreaks of Filovirus Hemorrhagic Fever: Time to Refocus on the Patient
40. Marburg Virus Angola Infection of Rhesus Macaques: Pathogenesis and Treatment with Recombinant Nematode Anticoagulant Protein c2
41. Epitopes Required for Antibody-Dependent Enhancement of Ebola Virus Infection
42. Ebola Hemorrhagic Fever: Evaluation of Passive Immunotherapy in Nonhuman Primates
43. Lymphocyte Death in a Mouse Model of Ebola Virus Infection
44. Recombinant Human Activated Protein C for the Postexposure Treatment of Ebola Hemorrhagic Fever
45. Pathologic Findings Associated with Delayed Death in Nonhuman Primates Experimentally Infected with Zaire Ebola Virus
46. Postexposure Protection of Guinea Pigs against a Lethal Ebola Virus Challenge Is Conferred by RNA Interference
47. Mechanisms Underlying Coagulation Abnormalities in Ebola Hemorrhagic Fever: Overexpression of Tissue Factor in Primate Monocytes/Macrophages Is a Key Event
48. Pathogenesis of Experimental Ebola Virus Infection in Guinea Pigs
49. Ebola (Subtype Reston) Virus among Quarantined Nonhuman Primates Recently Imported from the Philippines to the United States
50. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.